CLEAR CELL RENAL CELL CANCER (CCRCC)
Clinical trials for CLEAR CELL RENAL CELL CANCER (CCRCC) explained in plain language.
Never miss a new study
Get alerted when new CLEAR CELL RENAL CELL CANCER (CCRCC) trials appear
Sign up with your email to follow new studies for CLEAR CELL RENAL CELL CANCER (CCRCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kidney cancer patients with bone metastases: drug combo trial launches
Disease control Not yet recruitingThis study tests a new drug called zanzalintinib, taken with a bone-strengthening agent, in 20 people whose kidney cancer has spread to the bones and has worsened after prior immunotherapy. The goal is to see if this combination can stop the cancer from growing for at least 12 mo…
Matched conditions: CLEAR CELL RENAL CELL CANCER (CCRCC)
Phase: PHASE2 • Sponsor: Kelly Fitzgerald, MD • Aim: Disease control
Last updated May 17, 2026 05:47 UTC
-
New hope for kidney cancer patients with liver spread: drug combo trial launches
Disease control Not yet recruitingThis study tests a combination of two drugs (envafolimab and lenvatinib) as the first treatment for people with clear cell kidney cancer that has spread to the liver. The goal is to see if the combo can shrink liver tumors and help patients live longer. About 30 adults aged 18-75…
Matched conditions: CLEAR CELL RENAL CELL CANCER (CCRCC)
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated May 13, 2026 16:01 UTC